Qiagen (NYSE:QGEN – Get Free Report) issued an update on its FY23 earnings guidance on Monday morning. The company provided EPS guidance of $2.07 for the period, compared to the consensus EPS estimate of $2.06. The company issued revenue guidance of $1.97 billion, compared to the consensus revenue estimate of $1.97 billion. Qiagen Price Performance […]
Premier Fund Managers Ltd trimmed its position in shares of Qiagen (NYSE:QGEN – Free Report) by 0.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 187,956 shares of the company’s stock after selling 815 shares during the period. Premier Fund Managers Ltd owned […]
Shares of Qiagen (NYSE:QGEN – Get Free Report) reached a new 52-week low on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $55.00 to $50.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Qiagen traded as low as $38.13 and last traded at $38.22, with […]
Vontobel Holding Ltd. lifted its stake in shares of Qiagen (NYSE:QGEN – Free Report) by 3.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 52,304 shares of the company’s stock after buying an additional 1,561 shares during the quarter. Vontobel Holding Ltd.’s holdings […]
Qiagen (NYSE:QGEN – Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 3,240,000 shares, a drop of 16.1% from the August 31st total of 3,860,000 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average daily […]